Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
Á¦¸ñ 2015³â ´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°úºÐ°ú Ãá°è ¿¬¼ö°­ÁÂ
±â°£ 2015.08.15 - 2015.08.15
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

ÀÏ ½Ã : 2015³â 8¿ù 15ÀÏ(Åä)

Àå ¼Ò : º£½ºÆ®¿þ½ºÅÏ ¼­¿ï°¡µçÈ£ÅÚ 2Ãþ ±×·£µåº¼·ý A,BȦ

ȨÆäÀÌÁö :http://www.kaim.or.kr/workshop/201503/p02_t.html

 

¿¬¼ö°­Á ÀÏÁ¤:

09:00 - 09:10Opening RemarkÇ÷¾×Á¾¾ç³»°úºÐ°úÀ§¿øÈ¸ À§¿øÀå ÀÓ¿µÇõ
Session ¥°. Medical Oncologist¡¯s Role in Multidisciplinary Teams I
: Focus on Adjuvant & Neo-adjuvant Therapy
<ÁÂÀå: ¾ÈÁß¹è>
09:10 - 09:40LungÀÌ´ëÈ£ (¿ï»êÀÇ´ë)
09:40 - 10:10Stomach¿Àµµ¿¬ (¼­¿ïÀÇ´ë)
10:10 - 10:40 ColonÁ¶»óÈñ (Àü³²ÀÇ´ë)
10:40 ~ 11:00 Coffee Break
Session ¥±. Medical Oncologist¡¯s Role in Multidisciplinary Teams II
: Focus on Adjuvant & Neo-adjuvant Therapy
<ÁÂÀå: À±È¯Áß>
11:00 - 11:30 Head and Neck ±èÇý·Ã (¿¬¼¼ÀÇ´ë)
11:30 - 12:00 BreastäÀǼö (°æºÏÀÇ´ë)
12:00 ~ 13:00 Lunch
Session ¥². Updates in the Management of AML<ÁÂÀå: Á¤Ã¶¿ø>
13:00 ~ 13:30 Cytogenetically normal AML ¾öÁöÀº (ÇѾçÀÇ´ë)
13:30 ~ 14:00 Relapsed/refractory AML ±è¹Î°æ (¿µ³²ÀÇ´ë)
14:00 ~ 14:30 Therapy-related or secondary AML Á¶º´½Ä (°¡Å縯ÀÇ´ë)
14:30 ~ 14:50 Coffee Break
Session ¥³. Updates in the Management of NHL <ÁÂÀå: ¿øÁ¾È£>
14:50 ~ 15:20 DLBCL ÀÓ¼º³² (ÀÎÁ¦ÀÇ´ë)
15:20 ~ 15:50 PTCL ±è¼®Áø (¼º±Õ°üÀÇ´ë)
15:50 ~ 16:00Closing Remark Ç÷¾×Á¾¾ç³»°úºÐ°úÀ§¿øÈ¸ À§¿øÀå ÀÓ¿µÇõ

       


2015-07-18 ¿ÀÈÄ 8:55:31, Á¶È¸¼ö : 1641